NO744590L - - Google Patents
Info
- Publication number
- NO744590L NO744590L NO744590A NO744590A NO744590L NO 744590 L NO744590 L NO 744590L NO 744590 A NO744590 A NO 744590A NO 744590 A NO744590 A NO 744590A NO 744590 L NO744590 L NO 744590L
- Authority
- NO
- Norway
- Prior art keywords
- reaction
- stated
- carried out
- semi
- mol
- Prior art date
Links
- 238000006243 chemical reaction Methods 0.000 claims description 19
- 150000001780 cephalosporins Chemical class 0.000 claims description 13
- 229930186147 Cephalosporin Natural products 0.000 claims description 12
- 229940124587 cephalosporin Drugs 0.000 claims description 12
- 238000000034 method Methods 0.000 claims description 11
- 238000003786 synthesis reaction Methods 0.000 claims description 9
- 230000015572 biosynthetic process Effects 0.000 claims description 8
- 239000000126 substance Substances 0.000 claims description 7
- 230000002255 enzymatic effect Effects 0.000 claims description 6
- 108010073038 Penicillin Amidase Proteins 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical group N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 claims description 4
- 238000005917 acylation reaction Methods 0.000 claims description 2
- 230000001580 bacterial effect Effects 0.000 claims description 2
- 230000007071 enzymatic hydrolysis Effects 0.000 claims description 2
- 238000006047 enzymatic hydrolysis reaction Methods 0.000 claims description 2
- 229910052739 hydrogen Inorganic materials 0.000 claims description 2
- 239000008363 phosphate buffer Substances 0.000 claims description 2
- 241000588722 Escherichia Species 0.000 claims 2
- 239000001257 hydrogen Substances 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 9
- HSHGZXNAXBPPDL-HZGVNTEJSA-N 7beta-aminocephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C([O-])=O)N2C(=O)[C@@H]([NH3+])[C@@H]12 HSHGZXNAXBPPDL-HZGVNTEJSA-N 0.000 description 8
- 239000008057 potassium phosphate buffer Substances 0.000 description 8
- 239000000284 extract Substances 0.000 description 7
- 108090000790 Enzymes Proteins 0.000 description 6
- 102000004190 Enzymes Human genes 0.000 description 6
- 241000588724 Escherichia coli Species 0.000 description 6
- NVIAYEIXYQCDAN-CLZZGJSISA-N 7beta-aminodeacetoxycephalosporanic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)[C@@H](N)[C@@H]12 NVIAYEIXYQCDAN-CLZZGJSISA-N 0.000 description 5
- 238000005119 centrifugation Methods 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 238000006460 hydrolysis reaction Methods 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- NVIAYEIXYQCDAN-UHFFFAOYSA-N 7-amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Chemical compound S1CC(C)=C(C(O)=O)N2C(=O)C(N)C12 NVIAYEIXYQCDAN-UHFFFAOYSA-N 0.000 description 4
- 239000003795 chemical substances by application Substances 0.000 description 4
- 230000007062 hydrolysis Effects 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 125000000738 acetamido group Chemical group [H]C([H])([H])C(=O)N([H])[*] 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- DKPFZGUDAPQIHT-UHFFFAOYSA-N butyl acetate Chemical compound CCCCOC(C)=O DKPFZGUDAPQIHT-UHFFFAOYSA-N 0.000 description 2
- YGBFLZPYDUKSPT-MRVPVSSYSA-N cephalosporanic acid Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)C[C@H]21 YGBFLZPYDUKSPT-MRVPVSSYSA-N 0.000 description 2
- HOKIDJSKDBPKTQ-GLXFQSAKSA-N cephalosporin C Chemical compound S1CC(COC(=O)C)=C(C(O)=O)N2C(=O)[C@@H](NC(=O)CCC[C@@H](N)C(O)=O)[C@@H]12 HOKIDJSKDBPKTQ-GLXFQSAKSA-N 0.000 description 2
- 235000019441 ethanol Nutrition 0.000 description 2
- 238000000855 fermentation Methods 0.000 description 2
- 230000004151 fermentation Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 239000011541 reaction mixture Substances 0.000 description 2
- KIYRSYYOVDHSPG-SSDOTTSWSA-N (2r)-2-amino-2-phenylacetamide Chemical compound NC(=O)[C@H](N)C1=CC=CC=C1 KIYRSYYOVDHSPG-SSDOTTSWSA-N 0.000 description 1
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 1
- 125000004203 4-hydroxyphenyl group Chemical group [H]OC1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- ZGUNAGUHMKGQNY-ZETCQYMHSA-N L-alpha-phenylglycine zwitterion Chemical compound OC(=O)[C@@H](N)C1=CC=CC=C1 ZGUNAGUHMKGQNY-ZETCQYMHSA-N 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 230000002378 acidificating effect Effects 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- -1 alkyl radical Chemical group 0.000 description 1
- 125000003368 amide group Chemical group 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- BFNBIHQBYMNNAN-UHFFFAOYSA-N ammonium sulfate Chemical compound N.N.OS(O)(=O)=O BFNBIHQBYMNNAN-UHFFFAOYSA-N 0.000 description 1
- 229910052921 ammonium sulfate Inorganic materials 0.000 description 1
- 235000011130 ammonium sulphate Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000008346 aqueous phase Substances 0.000 description 1
- IYNDLOXRXUOGIU-LQDWTQKMSA-M benzylpenicillin potassium Chemical compound [K+].N([C@H]1[C@H]2SC([C@@H](N2C1=O)C([O-])=O)(C)C)C(=O)CC1=CC=CC=C1 IYNDLOXRXUOGIU-LQDWTQKMSA-M 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- FUBBGQLTSCSAON-PBFPGSCMSA-N cefaloglycin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)COC(=O)C)C(O)=O)=CC=CC=C1 FUBBGQLTSCSAON-PBFPGSCMSA-N 0.000 description 1
- 229950004030 cefaloglycin Drugs 0.000 description 1
- ZAIPMKNFIOOWCQ-UEKVPHQBSA-N cephalexin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@@H]3N(C2=O)C(=C(CS3)C)C(O)=O)=CC=CC=C1 ZAIPMKNFIOOWCQ-UEKVPHQBSA-N 0.000 description 1
- 229940106164 cephalexin Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- MLSGRWDEDYJNER-UHFFFAOYSA-N ethyl 2-anilinoacetate Chemical compound CCOC(=O)CNC1=CC=CC=C1 MLSGRWDEDYJNER-UHFFFAOYSA-N 0.000 description 1
- 239000012467 final product Substances 0.000 description 1
- 230000003301 hydrolyzing effect Effects 0.000 description 1
- 239000002198 insoluble material Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- WCYWZMWISLQXQU-UHFFFAOYSA-N methyl Chemical compound [CH3] WCYWZMWISLQXQU-UHFFFAOYSA-N 0.000 description 1
- 150000004702 methyl esters Chemical class 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- KINULKKPVJYRON-PVNXHVEDSA-N n-[(e)-[10-[(e)-(4,5-dihydro-1h-imidazol-2-ylhydrazinylidene)methyl]anthracen-9-yl]methylideneamino]-4,5-dihydro-1h-imidazol-2-amine;hydron;dichloride Chemical compound Cl.Cl.N1CCN=C1N\N=C\C(C1=CC=CC=C11)=C(C=CC=C2)C2=C1\C=N\NC1=NCCN1 KINULKKPVJYRON-PVNXHVEDSA-N 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000012429 reaction media Substances 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/04—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by acylation of the substituent in the 7 position
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P35/00—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin
- C12P35/02—Preparation of compounds having a 5-thia-1-azabicyclo [4.2.0] octane ring system, e.g. cephalosporin by desacylation of the substituent in the 7 position
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Cephalosporin Compounds (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT5448473 | 1973-12-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
NO744590L true NO744590L (fr) | 1975-07-14 |
Family
ID=11287332
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO744590A NO744590L (fr) | 1973-12-20 | 1974-12-19 |
Country Status (18)
Country | Link |
---|---|
JP (1) | JPS5095486A (fr) |
AU (1) | AU7608974A (fr) |
BE (1) | BE823392A (fr) |
CA (1) | CA1018091A (fr) |
CS (1) | CS209853B2 (fr) |
DD (1) | DD116833A5 (fr) |
DE (1) | DE2460607A1 (fr) |
DK (1) | DK660374A (fr) |
FR (1) | FR2255380B1 (fr) |
GB (1) | GB1480850A (fr) |
HU (1) | HU172077B (fr) |
IL (1) | IL46150A (fr) |
LU (1) | LU71506A1 (fr) |
NL (1) | NL7416549A (fr) |
NO (1) | NO744590L (fr) |
SE (1) | SE7416077L (fr) |
YU (1) | YU335674A (fr) |
ZA (1) | ZA747895B (fr) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2105988B1 (es) * | 1996-03-15 | 1998-07-01 | Antibioticos Sa | Procedimiento para purificar 7-sustituido-amino-desacetoxi-cefalosporinas mediante el empleo de membranas de filtracion. |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS5310156B2 (fr) * | 1972-10-21 | 1978-04-11 | ||
JPS52118A (en) * | 1975-06-23 | 1977-01-05 | Sony Corp | Still picture reproducing device |
-
1974
- 1974-11-28 IL IL46150A patent/IL46150A/xx unknown
- 1974-12-05 AU AU76089/74A patent/AU7608974A/en not_active Expired
- 1974-12-11 ZA ZA00747895A patent/ZA747895B/xx unknown
- 1974-12-12 FR FR7440980A patent/FR2255380B1/fr not_active Expired
- 1974-12-16 GB GB54336/74A patent/GB1480850A/en not_active Expired
- 1974-12-16 BE BE151538A patent/BE823392A/fr not_active IP Right Cessation
- 1974-12-17 LU LU71506A patent/LU71506A1/xx unknown
- 1974-12-17 YU YU03356/74A patent/YU335674A/xx unknown
- 1974-12-18 DK DK660374A patent/DK660374A/da not_active Application Discontinuation
- 1974-12-18 DD DD183150A patent/DD116833A5/xx unknown
- 1974-12-18 NL NL7416549A patent/NL7416549A/xx active Search and Examination
- 1974-12-19 CA CA216,466A patent/CA1018091A/fr not_active Expired
- 1974-12-19 HU HU74SA00002731A patent/HU172077B/hu unknown
- 1974-12-19 SE SE7416077A patent/SE7416077L/xx unknown
- 1974-12-19 NO NO744590A patent/NO744590L/no unknown
- 1974-12-20 DE DE19742460607 patent/DE2460607A1/de active Pending
- 1974-12-20 CS CS748821A patent/CS209853B2/cs unknown
- 1974-12-20 JP JP49145850A patent/JPS5095486A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
DD116833A5 (fr) | 1975-12-12 |
LU71506A1 (fr) | 1975-06-17 |
ZA747895B (en) | 1976-01-28 |
IL46150A (en) | 1979-07-25 |
DE2460607A1 (de) | 1975-06-26 |
JPS5095486A (fr) | 1975-07-29 |
DK660374A (fr) | 1975-08-25 |
GB1480850A (en) | 1977-07-27 |
CA1018091A (fr) | 1977-09-27 |
NL7416549A (nl) | 1975-06-24 |
SE7416077L (fr) | 1975-06-23 |
CS209853B2 (en) | 1981-12-31 |
AU7608974A (en) | 1976-06-10 |
BE823392A (fr) | 1975-04-16 |
YU335674A (en) | 1982-05-31 |
HU172077B (hu) | 1978-05-28 |
IL46150A0 (en) | 1975-02-10 |
FR2255380A1 (fr) | 1975-07-18 |
FR2255380B1 (fr) | 1977-11-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2086250C (fr) | Mode de preparation de beta-lactames | |
EP1141372A2 (fr) | Production in vivo amelioree de cephalosporines | |
EP1831390B1 (fr) | Procedé pour la synthèse du cefaclor | |
US3945888A (en) | Method for the production of cephalosporins | |
WO1997004086A1 (fr) | Penicilline g acylase immobilisee amelioree | |
NO115254B (fr) | ||
JPH022396A (ja) | セファロスポリンc及び類似体の一段階酵素反応による7‐アミノセファロスポラン酸及びその類似体への変換 | |
US3880713A (en) | Cephalosporin compounds | |
Okachi et al. | Penicillin acylase of Pseudomonas melanogenum KY 3987 | |
NO744590L (fr) | ||
JPS589680B2 (ja) | アミノカゴウブツノ セイホウ | |
US3972774A (en) | Enzymatic de-esterification of cephalosporin para-nitrobenzyl esters | |
US3862004A (en) | Method for production of cephalosporins | |
US6156534A (en) | Synthesis of β-lactam antibacterials using soluble side chain esters and enzyme acylase | |
McDougall et al. | Enzymic acylation of 6-aminopenicillanic acid | |
US3976546A (en) | Cephalosporins | |
EP0730036B1 (fr) | Procédé pour la synthèse enzymatique d'antibiotiques bèta-lactame en présence d'un inhibiteur d'enzyme | |
US3787288A (en) | Method for preparing alpha-aminobenzylpenicillin | |
Perlin et al. | Studies on the decomposition of cellulose by micro-organisms | |
US7588913B2 (en) | Process for the preparation of cephradine | |
EP0638649A2 (fr) | Nouvelle application de penicillin G acylase d'alcaligènes faecalis | |
WO2002020819A2 (fr) | Procede enzymatique pour l'elaboration de composes a base de beta-lactamines | |
JPS557A (en) | Production of ceftezole | |
CH621575A5 (en) | Process for the enzymatic hydrolysis of cephalosporins | |
JPH01242590A (ja) | 3−メトキシメチルセファロスポラン酸誘導体とその製造方法および7−アミノ−3−アルコキシメチルセファロスポラン酸の製造法 |